/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

V

Vera Hirsh

McGill University(CA)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

267

Papers

32.8K

Citations

61

h-index

135

i10-index

Vera Hirsh is an academic researcher from McGill University. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Lung Cancer Research Studies & Colorectal Cancer Treatments and Studies. The author has an h-index of 61, co-authored 227 publications.

Research Topics

Lung Cancer Treatments and Mutations Lung Cancer Research Studies Colorectal Cancer Treatments and Studies Lung Cancer Diagnosis and Treatment HER2/EGFR in Cancer Research

Papers by this author

works

Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma

2011 · Journal of Clinical Oncology · 1,250 citations

https://doi.org/10.1200/jco.2010.31.3304

David H. Henry Luís Costa François Goldwasser Vera Hirsh

Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial

2016 · The Lancet Oncology · 1,143 citations

https://doi.org/10.1016/s1470-2045(16)30033-x

Keunchil Park Eng-Huat Tan Kenneth J. O’Byrne Li Zhang

Final results of the large-scale multinational trial PROFILE 1005: efficacy and safety of crizotinib in previously treated patients with advanced/metastatic ALK-positive non-small-cell lung cancer

2017 · ESMO Open · 106 citations

https://doi.org/10.1136/esmoopen-2017-000219

Fiona Blackhall D. Ross Camidge Alice T. Shaw Jean‐Charles Soria

Immunotherapy Bridge 2016 and Melanoma Bridge 2016: meeting abstracts

2017 · Journal of Translational Medicine · 43 citations

https://doi.org/10.1186/s12967-016-1095-2

Vera Hirsh Sandro Pignata Melissa Bersanelli Letizia Gnetti

Melanoma and immunotherapy bridge 2015

2016 · Journal of Translational Medicine · 24 citations

https://doi.org/10.1186/s12967-016-0791-2

Vashisht Gopal Yennu Nanda Weiyi Peng Patrick Hwu Michael A. Davies

Phase II study of two dose schedules of C.E.R.A. (Continuous Erythropoietin Receptor Activator) in anemic patients with advanced non-small cell lung cancer (NSCLC) receiving chemotherapy

2007 · Trials · 13 citations

https://doi.org/10.1186/1745-6215-8-8

Vera Hirsh John A. Glaspy Paul N. Mainwaring Christian Manegold

Research topics

topics

Lung Cancer Treatments and Mutations

Lung Cancer Research Studies

Colorectal Cancer Treatments and Studies

Lung Cancer Diagnosis and Treatment

HER2/EGFR in Cancer Research

Chat about Author

Papers

Chat

Click to start Chat